analyzed after dilution of 1.0 ml of the platelet suspension by 4.0 ml ofO.9% NaCI.
Collection ofRecipient Sera
Sera from all patients were collected at study entry and at intervals of 2-3 wk throughout the study period. In all but 3 patients surviving the study period, an additional final serum was obtained 6-30 (mean I 4. 1) days after the last platelet transfusion. All sera were kept at -80#{176}Cuntil testing. donors of blood group 0, were used as antigens.
Histocompatibility Testing and Antibody Screening
A test was considered positive if the counts per minute (cpm) exceeded the mean ±3 SD (i.e., mean ± 30%) of 30 normal sera tested. 
Evaluation of Transfusion Responses
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